Sanofi and Regeneron Pharmaceuticals, Inc. announced their intent to simplify their antibody collaboration for Kevzara (sarilumab) and Praluent (alirocumab) by...
Background: Asthma is among the most common causes of chronic cough in adult nonsmokers. Although cough usually accompanies dyspnea and wheezing, it may present in isolation as a precursor of typical asthmatic symptoms, or it may remain the predominant or sole symptom of asthma.
Athenex, Inc. a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, led by its Orascovery platform, announced that it has acquired Kuur Therapeutics, Inc., the leading developer of off-the-shelf CAR-NKT cell immunotherapies for the treatment of solid and hematological malignancies.
Birken AG, a biopharmaceutical and dermo-cosmetic company has announced that the European Medicines Agency (EMA) has accepted its Oleogel-S10 Marketing...
Cerecor Inc. a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and...
The FDA has approved Orenitram (treprostinil) Extended-Release Tablets, from United Therapeutics, for the oral treatment of Pulmonary Arterial Hypertension (PAH)...
The FDA has agreed to Discovery Lab's updated product specifications for Surfaxin (lucinactant) Intratracheal Suspension which was approved in 2012...
The FDA has approved the CliniMACS CD34 Reagent System, from Miltenyi Biotec, as a Humanitarian Use Device for the prevention...